Asian Spectator

Men's Weekly

.

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

  • Written by ACN Newswire - Press Releases

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

SHANGHAI, CHINA, Jul 20, 2020 - (ACN Newswire) - Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed US$97 million in Series C financing.

The...

More Articles ...

  1. Top 7 Benefits That a CBD-Rich Oil Can Potentially Offer
  2. Australians concerned about their financial wellbeing as a result of COVID-19
  3. Fivetran Raises $100 Million to Accelerate Growth as Automated Data Integration Leader
  4. Commodities Intelligence Centre (CIC) introduces international Trade Data and Business Services, partners SBF to drive digital transformation of Singapore SMEs

Magazine

Hampir separuh masyarakat Indonesia tak mampu beli makanan sehat: Koreksi untuk sistem pangan kita

● Separuh warga Indonesia kesulitan membeli pangan sehat karena akses terbatas dan harga tinggi.● Sektor pertanian berfokus pada komoditas ekspor, bukan pangan sehari-hari.● Keterga...

Jejak seni tertua umat manusia ditemukan di Sulawesi

SuppliedSelama ini, Eropa kerap dianggap sebagai titik awal sejarah seni dunia. Deretan lukisan gua tersohor di Prancis dan Spanyol sering kali dijadikan bukti bahwa wilayah tersebut merupakan simbol ...

PBB sebut dunia memasuki era kebangkrutan air, tanda-tandanya sudah nyata

Di tengah perubahan iklim, dunia masih saja menggunakan air tawar dalam jumlah yang sangat besar. Akibatnya, kita mencapai titik yang disebut sebagai era kebangkrutan air. Banyak wilayah kini tidak la...